Notice:  As we transition our hotline team back to in-office services, we remain focused on responding to patient inquiries. We kindly ask pharmacies, providers, and their staff to continue to use our Pharmacy and Provider Portals. If you have a question that cannot be answered by visiting the portal, please send an email to grants@healthwellfoundation.org. We appreciate your patience and look forward to serving you. The HealthWell Team

Dismiss alert
By Cancer Support Community  |  Aug 24, 2022

Managing Side Effects of Acute Lymphoblastic Leukemia Treatment

As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC), including its Gilda’s Club affiliates, is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. CSC achieves its mission through three areas: direct…more.

Categories: Leukemia
By Real World Health Care Editorial Staff  |  Jun 15, 2022

Cancer Research Belongs in the Community

Studies have shown that cancer disproportionately impacts racial and ethnic minority groups, however, these groups remain underrepresented in cancer clinical trials.1,2,3 With unique insights into issues facing underrepresented patient populations, the Association of Community Cancer Centers (ACCC) recently developed consensus-driven recommendations to improve diversity, equity and accessibility in cancer research.…more.

Categories: Health Disparities
By Real World Health Care Editorial Staff  |  Aug 4, 2021

Understanding Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a cancer that affects the blood and bone marrow and is the most common type of acute leukemia in adults. With AML, the bone marrow (the center of the bone containing many blood vessels) makes abnormal white blood cells, red blood cells or platelets. Normally,…more.

Categories: Leukemia
By Real World Health Care Editorial Staff  |  Jun 9, 2021

Lessons Learned: Cancer Care during COVID

Last March, as the COVID-19 pandemic started its relentless progression across the United States, hospitals and clinics nationwide closed their doors to all but the most gravely ill patients. While certain elective procedures and well visits were paused temporarily, patients with cancer didn’t have the luxury of waiting for things…more.

Categories: COVID 19
By Real World Health Care Editorial Staff  |  Nov 23, 2020

Lung Cancer Awareness Month: Trends, Advocacy and Caregivers in the Spotlight

November is Lung Cancer Awareness Month, a time when the medical community, patients and their loved ones, advocacy organizations and industry come together to raise awareness and support for the number one cancer killer of men and women in the United States. Lung Cancer Trends For example, this year, the…more.

By Claire Saxton, Vice President, Education and Outreach, Cancer Support Community  |  Sep 2, 2020

CAR-T Cell Immunotherapy: What to Expect

As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC), including its Gilda’s Club affiliates, is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. CSC achieves its mission through three areas: direct…more.

By Real World Health Care Editorial Staff  |  Jul 22, 2020

CAR T-Cell Therapy Gave Me Back My Life

Editor’s Note: This week, Real World Health Care shares an inspirational story of a woman who was diagnosed with lymphoma and received treatment with CAR T-cell therapy. “CAR-T Cell Therapy Gave Me My Life Back” is reprinted with permission from the Association of Community Cancer Centers. Updated in April 2020,…more.

By Real World Health Care Editorial Staff  |  Jun 24, 2020

Does CAR-T Cell Therapy Belong in Community Clinics?

CAR T-cell therapy (CAR-T) has emerged as a highly innovative and promising option for patients with cancer. Until recently, the use of CAR-T has been restricted to small clinical trials, primarily with patients with advanced blood cancers. These trials often are conducted at large, academic medical centers in major metropolitan…more.

By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Mar 11, 2020

Search & Destroy: Chimeric Antigen Receptor T-Cells (CAR-T)

Editor’s Note: The following article is reprinted, with permission from Biotech Primer. The original version appeared in the Biotech Primer WEEKLY. To subscribe to the Biotech Primer WEEKLY, click here. The first (and so far, only) chimeric antigen receptor T-cell (CAR-T) therapies—tisagenlecleucel and axicabtagene ciloleucel were approved in 2017, and…more.

By Alexandra Zaleta, PhD, Senior Director, Research, Cancer Support Community  |  Sep 25, 2019

Understanding the Voice of Cancer Caregivers

At the Cancer Support Community, we have always strived to serve everyone who has been affected by cancer. For us, this means providing support to patients as well as their family members, who often play a critical role in providing support and care. It also means conducting research that prioritizes…more.

Categories: Caregiving, General
Close menu